SexAnnoDB Logo

Home

Download

Statistics

Examples

Help

Contact

Center for Computational Systems Medicine
leaf

Gene summary

leaf

Gene structure and Gene expression level

leaf

Sex-biased somatic mutation

leaf

DNA methylation with beta values in gene

leaf

Exon skipping events with PSI in TCGA

leaf

RNA A-to-I editing events in TCGA

leaf

Sex-biased TF-Gene network of gene

leaf

Sex-biased RBP-ES network of gene

leaf

Sex-biased CeRNA regulation of gene

leaf

Sex-biased eQTL regulation of gene

leaf

Sex-biased eQTM regulation of gene

leaf

Sex-biased sQTL regulation of gene

leaf

Sex-biased sQTM regulation of gene

leaf

Related disease information of gene

Gene: ENSG00000117394

Summary for SLC2A1

check button Gene summary

Gene informationEnsembl ID

ENSG00000117394

Gene symbol

SLC2A1

Gene namesolute carrier family 2 member 1
HGNC

11005

Entrez ID

6513

Gene typeprotein_coding
SynonymsSLC2A1|DYT18|DYT9|GLUT-1
UniProtAcc

P11166


check buttonDrugs associated with this gene(DrugBank).
Gene IDGene SymbolDrug IDDrug NameDrug Type

check buttonCancer therapeutic drugs associated with this gene(NCI).
Gene IDGene NameDrug IDDrug NameDrug TypeCancer

Top

Structure and expression level for SLC2A1

check buttonAS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.
∗For more information on exon skipping events please check the ExonskipDB database.
∗For more information on exon skipping events please check the CAeditome database.
UCSC result

check buttonLandscape of gene expressions across multiple cancer types.
gene expression analysis

check buttonDifferentially expressed gene analysis between tumor male and tumor female samples.
DEG result
Coding NameBase Meanlog2FoldChangelfcSEStatP valueP.adjust ValueCancer Type
SLC2A15.04e+03-1.37e+002.05e-01-6.67e+002.58e-112.16e-09KIRP

check buttonDifferentially expressed gene analysis between tumor male and normal male samples.
DEG result
Coding NameBase Meanlog2FoldChangelfcSEStatP valueP.adjust ValueCancer Type
SLC2A14.62e+043.01e+005.56e-015.42e+006.09e-082.37e-06ESCA
SLC2A11.52e+033.20e+007.03e-014.56e+005.20e-063.15e-05CHOL

check buttonDifferentially expressed gene analysis between tumor female and normal female samples.
DEG result
Coding NameBase Meanlog2FoldChangelfcSEStatP valueP.adjust ValueCancer Type
SLC2A16.94e+031.49e+001.04e-011.44e+017.01e-476.42e-46BRCA
SLC2A11.12e+041.77e+004.54e-013.89e+009.99e-054.79e-04READ

Top

Sex-biased somatic mutation for SLC2A1

∗For more information on exon skipping events please check the ExonskipDB database.
Gene IDCancer TypeHugo SymbolMaleFemalepvalorci.upci.lowadjPval

Top

DNA methylation with beta values for SLC2A1

check buttonLandscape of DNA methylation across multiple cancer types.
methylation heatmap

check buttonDifferentially expressed CpG sites between male tumor and female tumor patients.
Cancer TypeCpG SitePositionCpG IslandPosition to Geneave1ave2wilcoxon.wwilcoxon.ppadjdBeta
KIRPcg05802386chr1:42957249CGI:chr1:42957796-42959097promoter,gene body6.69e-017.74e-01-2.79e+005.31e-031.44e-02-1.05e-01
KIRPcg20282814chr1:42957401CGI:chr1:42957796-42959097promoter,gene body6.84e-017.94e-01-3.17e+001.55e-036.52e-03-1.10e-01
MESOcg05802386chr1:42957249CGI:chr1:42957796-42959097promoter,gene body8.20e-017.04e-012.01e+004.46e-024.86e-021.16e-01

check buttonDifferentially expressed CpG sites between male tumor and male normal patients.
Cancer TypeCpG SitePositionCpG IslandPosition to Geneave1ave2wilcoxon.wwilcoxon.ppadjdBeta
LUSCcg05802386chr1:42957249CGI:chr1:42957796-42959097promoter,gene body3.65e-018.06e-01-4.47e+007.65e-065.26e-04-4.41e-01
LUSCcg20282814chr1:42957401CGI:chr1:42957796-42959097promoter,gene body4.47e-018.74e-01-4.45e+008.73e-065.26e-04-4.27e-01
LUSCcg12101479chr1:42960422CGI:chr1:42957796-42959097promoter7.83e-019.07e-01-3.64e+002.72e-041.15e-03-1.24e-01
COADcg05802386chr1:42957249CGI:chr1:42957796-42959097promoter,gene body2.96e-013.96e-01-3.28e+001.05e-032.33e-03-1.00e-01
BLCAcg12101479chr1:42960422CGI:chr1:42957796-42959097promoter7.82e-019.03e-01-3.63e+002.79e-048.50e-04-1.21e-01
LIHCcg12101479chr1:42960422CGI:chr1:42957796-42959097promoter6.57e-018.47e-01-3.53e+004.08e-047.15e-04-1.91e-01
KIRPcg05802386chr1:42957249CGI:chr1:42957796-42959097promoter,gene body7.74e-016.17e-013.96e+007.52e-052.03e-041.57e-01
KIRPcg20282814chr1:42957401CGI:chr1:42957796-42959097promoter,gene body7.94e-016.51e-013.91e+009.14e-052.40e-041.44e-01
CHOLcg26188818chr1:42957976CGI:chr1:42957796-42959097promoter,gene body4.03e-022.64e-01-3.54e+004.02e-048.32e-03-2.24e-01
CHOLcg04287330chr1:42957925CGI:chr1:42957796-42959097promoter,gene body6.74e-022.50e-01-3.54e+004.02e-048.32e-03-1.82e-01

check buttonDifferentially expressed CpG sites between female tumor and female normal patients.
Cancer TypeCpG SitePositionCpG IslandPosition to Geneave1ave2wilcoxon.wwilcoxon.ppadjdBeta
BRCAcg05802386chr1:42957249CGI:chr1:42957796-42959097promoter,gene body4.14e-016.90e-01-1.24e+012.62e-358.13e-34-2.76e-01
BRCAcg20282814chr1:42957401CGI:chr1:42957796-42959097promoter,gene body4.50e-017.08e-01-1.16e+014.00e-316.71e-30-2.58e-01
KIRCcg20282814chr1:42957401CGI:chr1:42957796-42959097promoter,gene body5.12e-013.86e-012.28e+002.27e-022.93e-021.27e-01

Top

Exon skipping events with PSI in TCGA for SLC2A1

∗Please access ExonSkipDB for exon skipping annotation.
check buttonLandscape of exon skipping events across multiple cancer types.
AS event heatmap

check buttonDifferentially expressed exon skipping events between male tumor and female tumor patients.
Cancer TypeExon Skippingave.female_Tave.female_Nwilcoxon.wwilcoxon.ppadjdPSI

check buttonDifferentially expressed exon skipping events between male tumor and male normal patients.
Cancer TypeExon Skippingave.female_Tave.female_Nwilcoxon.wwilcoxon.ppadjdPSI

check buttonDifferentially expressed exon skipping events between female tumor and female normal patients.
Cancer TypeExon Skippingave.female_Tave.female_Nwilcoxon.wwilcoxon.ppadjdPSI

Top

RNA A-to-I editing events in TCGA for SLC2A1

∗Please access CAeditome for RNA editing annotation.
check buttonDifferentially expressed RNA editing events between male tumor and female tumor patients.
Cancer TypeTranscriptEditingave.male_Tave.female_Twilcoxon.wwilcoxon.pp_adjdFre

check buttonDifferentially expressed RNA editing events between male tumor and male normal patients.
Cancer TypeTranscriptEditingave.male_Tave.female_Twilcoxon.wwilcoxon.pp_adjdFre

check buttonDifferentially expressed RNA editing events between female tumor and female normal patients.
Cancer TypeTranscriptEditingave.male_Tave.female_Twilcoxon.wwilcoxon.pp_adjdFre

check buttonProtein coding RNA editing(s).
Editing PositionVariant TypeGene SymbolTranscript IDNTchangeAAchange

Top

Sex-biased TF-Gene network for SLC2A1

check buttonTFs related to SLC2A1.
∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98.
∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98.
TF Gene
Cancer TypeTFTarget GeneMale Edge ScoreMale Edge ThresholdFemale Edge ScoreFemale Edge ThresholdType
MESOZNF418SLC2A11.06e+002.22e-053.93e+009.84e-01Female-biased

check buttonSLC2A1 related gene.
∗Only the gene encode TF might with this result.
∗For more information please check Sex-biased TF-Coding gene network.

Top

Sex-biased RBP-ES network for SLC2A1

check buttonRBPs related to ES in SLC2A1.
∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98.
∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98.
RBP ES
Cancer TypeRBPTarget ESMale Edge ScoreMale Edge ThresholdFemale Edge ScoreFemale Edge ThresholdType
STADSAMD4Aexon_skip_256856.65e+009.81e-016.16e+002.92e-03Male-biased
UVMIGF2BP2exon_skip_256777.99e+008.74e-038.30e+009.84e-01Female-biased
UVMIGF2BP3exon_skip_256777.99e+008.67e-038.30e+009.84e-01Female-biased
THYMSRSF7exon_skip_256789.63e+003.24e-031.00e+019.95e-01Female-biased
LUSCSAMD4Aexon_skip_256787.22e+009.85e-016.70e+002.86e-03Male-biased
COADSAMD4Aexon_skip_256786.17e+001.43e-046.99e+009.86e-01Female-biased
KIRPSRSF7exon_skip_256789.60e+009.48e-039.94e+009.88e-01Female-biased
BRCASAMD4Aexon_skip_256786.47e+007.29e-037.19e+009.80e-01Female-biased
THCASAMD4Aexon_skip_256786.83e+009.83e-016.41e+001.80e-03Male-biased
THCASRSF7exon_skip_256789.43e+001.61e-039.88e+009.96e-01Female-biased
MESOSRSF7exon_skip_256789.76e+001.45e-021.01e+019.84e-01Female-biased
LGGSAMD4Aexon_skip_256787.01e+009.86e-016.24e+001.82e-04Male-biased
KIRCSAMD4Aexon_skip_256786.41e+001.92e-057.38e+009.89e-01Female-biased
KICHSRSF7exon_skip_256789.78e+009.95e-019.35e+003.12e-03Male-biased
SARCSAMD4Aexon_skip_256786.68e+004.80e-037.12e+009.82e-01Female-biased

check buttonSLC2A1 related ES.
∗Only the gene encode RBP might with this result.
∗For more information please check Sex-biased RBP-ES network in cancer.

Top

Sex-biased CeRNA regulation of gene

check buttonSex-biased CeRNA regulation of gene.
Gene IDceRNA(lncRNA-miRNA-mRNA)GroupCancer Type

Top

Sex-biased eQTL regulation of gene

check buttonSex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table).
eQTLDescription

check buttonMale-specific eQTL regulation.
SNP IDSNP InfoPosition to GeneEffect ScoreFDRCancer TypeBiased Type
rs11210595chr1:42122325:C:A-0.06910481013833950.0334577982285881LGGFemale-baised eQTL
rs11210596chr1:42122656:T:C-0.06910481013833950.0334577982285881LGGFemale-baised eQTL
rs1889127chr1:42113116:C:T-0.0666280697908130.0459695261055728LGGFemale-baised eQTL

check buttonFemale-specific eQTL regulation.
SNP IDSNP InfoPosition to GeneEffect ScoreFDRCancer TypeBiased Type
rs11264006chr1:37260296:C:G-0.2216265083964270.000106515343837495SARCMale-baised eQTL
rs72686073chr1:44280545:G:A-0.1343210461586160.00509353721594557SARCMale-baised eQTL
rs41270415chr1:44219992:C:T-0.1293566615356920.00703406372611405SARCMale-baised eQTL
rs3845493chr1:37092075:C:A-0.1869032989142020.0073872038379844SARCMale-baised eQTL
rs4652936chr1:37092200:G:A-0.1869032989142020.0073872038379844SARCMale-baised eQTL
rs7539225chr1:41647852:A:G-0.1222794540677490.0398481229091728SARCMale-baised eQTL
rs7541822chr1:41648022:T:C-0.1222794540677490.0398481229091728SARCMale-baised eQTL
rs6699235chr1:41651774:A:T-0.1222794540677490.0398481229091728SARCMale-baised eQTL
rs78410207chr1:41646956:A:G-0.122090142177220.0408345599221373SARCMale-baised eQTL
rs28684469chr1:41646520:G:A-0.1219468300098430.0417883617708898SARCMale-baised eQTL
rs7535727chr1:48640618:G:T-0.07947375924395940.0282333671287199BLCAMale-baised eQTL
rs78645362chr1:48641687:A:G-0.07642452149690790.0383036950563118BLCAMale-baised eQTL
rs72653591chr1:37112530:C:T-0.05342685166110350.0388903834356923BLCAMale-baised eQTL
rs66626960chr1:37111819:C:T-0.05151768992786460.0409892136052398BLCAMale-baised eQTL
rs113087909chr1:32966260:T:C-0.06199547935291620.0421717268885757BLCAMale-baised eQTL
rs12058997chr1:48642154:T:C-0.07553880689974880.0433445538045455BLCAMale-baised eQTL
rs12121968chr1:43881422:T:C-0.112028488881060.026620833388594LUADMale-baised eQTL

check buttonOpposite sex-biased eQTL regulation.
SNP IDSNP InfoPosition to GeneMale EffectMale FDRFemale EffectFemale FDRSex-biased Gene in CancerCancer Type

Top

Sex-biased eQTM regulation of gene

check buttonSex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table).
eQTMDescription
eQTM boxplot analysisGene ID: ENSG00000117394
CpG Site: cg20294984
Position to Gene: gene
Male Effect: -0.434397980085227
Female Effect: -
eQTM boxplot analysisGene ID: ENSG00000117394
CpG Site: cg15089806
Position to Gene: gene
Male Effect: -0.434397980085227
Female Effect: -
eQTM boxplot analysisGene ID: ENSG00000117394
CpG Site: cg22025263
Position to Gene: gene
Male Effect: -0.434397980085227
Female Effect: -
eQTM boxplot analysisGene ID: ENSG00000117394
CpG Site: cg01924561
Position to Gene: gene
Male Effect: -0.302552493953019
Female Effect: -
eQTM boxplot analysisGene ID: ENSG00000117394
CpG Site: cg00737593
Position to Gene: gene
Male Effect: -0.302552493953019
Female Effect: -
eQTM boxplot analysisGene ID: ENSG00000117394
CpG Site: cg22025263
Position to Gene: gene
Male Effect: -0.489343652543117
Female Effect: -
eQTM boxplot analysisGene ID: ENSG00000117394
CpG Site: cg01924561
Position to Gene: gene
Male Effect: -0.480606116630326
Female Effect: -
eQTM boxplot analysisGene ID: ENSG00000117394
CpG Site: cg09502149
Position to Gene: gene
Male Effect: -0.227308248451405
Female Effect: -
eQTM boxplot analysisGene ID: ENSG00000117394
CpG Site: cg20282814
Position to Gene: gene,promoter
Male Effect: -0.227308248451405
Female Effect: -
eQTM boxplot analysisGene ID: ENSG00000117394
CpG Site: cg01924561
Position to Gene: gene
Male Effect: -0.43145197767196
Female Effect: -
eQTM boxplot analysisGene ID: ENSG00000117394
CpG Site: cg05802386
Position to Gene: gene,promoter
Male Effect: -0.43145197767196
Female Effect: -
eQTM boxplot analysisGene ID: ENSG00000117394
CpG Site: cg05942022
Position to Gene: gene
Male Effect: -0.207343056748781
Female Effect: -

check buttonMale-specific eQTM regulation.
CpG SiteCpG PostionPosition to GeneEffect ScoreFDRCor.rCor.PvalueCancer Type
cg20294984chr1:42947081gene-0.4343979800852271.47459920300325e-10-0.55107288810280591.194596106629555e-14COAD
cg15089806chr1:42952528gene-0.4343979800852271.47459920300325e-10-0.55107288810280591.194596106629555e-14COAD
cg22025263chr1:42953804gene-0.4343979800852271.47459920300325e-10-0.55107288810280591.194596106629555e-14COAD
cg01924561chr1:42950432gene-0.3025524939530195.25998923840328e-10-0.52273325198307814.2840968892139837e-13COAD
cg00737593chr1:42956666gene-0.3025524939530195.25998923840328e-10-0.52273325198307814.2840968892139837e-13COAD
cg22025263chr1:42953804gene-0.4893436525431171.08832141466371e-51-0.83559973041479171.140910334395682e-53KIRP
cg01924561chr1:42950432gene-0.4806061166303265.60336550243847e-28-0.6474304821516631.8907695962875325e-31LIHC
cg09502149chr1:42941121gene-0.2273082484514055.50162751120235e-10-0.440578344469435561.9428854042938896e-13LIHC
cg20282814chr1:42957401gene,promoter-0.2273082484514055.50162751120235e-10-0.440578344469435561.9428854042938896e-13LIHC
cg01924561chr1:42950432gene-0.431451977671962.11776439775625e-15-0.476924920902342568.055248959041847e-18LGG
cg05802386chr1:42957249gene,promoter-0.431451977671962.11776439775625e-15-0.476924920902342568.055248959041847e-18LGG
cg05942022chr1:42936920gene-0.2073430567487811.02793025303486e-06-0.328485318788345141.3510897387722229e-08LGG

check buttonFemale-specific eQTM regulation.
CpG SiteCpG PostionPosition to GeneEffect ScoreFDRCor.rCor.PvalueCancer Type

check buttonOpposite sex-biased eQTM regulation.
CpG SiteCpG PostionCpG IslandPosition to GeneMale EffectMale FDRFemale EffectFemale FDRMale CorMale P-valueFemale CorFemale P-valueSex-biased Coding GeneCancer Type

Top

Sex-biased sQTL regulation of gene

check buttonSex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table).
sQTLDescription

check buttonMale-specific sQTL regulation.
ES IDSkipped ExonORF AnnoSNP IDSNP InfoSNP Position to ESEffect ScoreFDRCancer TypeBiased Type

check buttonFemale-specific sQTL regulation.
ES IDSkipped ExonORF AnnoSNP IDSNP InfoSNP Position to ESEffect ScoreFDRCancer TypeBiased Type

check buttonOpposite sex-biased sQTL regulation.
ES IDSkipped ExonORF AnnoSNP IDSNP InfoSNP Position to ESMale EffectMale FDRFemale EffectFemale FDRCancer Type

Top

Sex-biased sQTM regulation of gene

check buttonSex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table).
sQTMDescription

check buttonMale-specific sQTM regulation.
EX IDSkipped ExonCPG SiteCPG PositionPosition to EX EventsEffect ScoreFDRCor.rCor.PvalueORF_annoCancer Type

check buttonFemale-specific sQTM regulation.
EX IDSkipped ExonCPG SiteCPG PositionPosition to EX EventsEffect ScoreFDRCor.rCor.PvalueORF_annoCancer Type

check buttonOpposite sex-biased sQTM regulation.
EX IDEX InfoSkipped ExonCPG SiteCPG PositionCPG IslandPosition to EX EventsMale EffectMale FDRFemale EffectFemale FDRMale CorrelationMale P-valueFemale CorrelationFemale P-valueORF_annoCancer Type

Top

Related disease information of SLC2A1

check buttonDiseases associated with this gene (DisGeNET).
Gene IDGene SymbolDisease IDDisease NameNumber of PMIDSource
ENSG00000117394SLC2A1C0004134Ataxia1CTD_human
ENSG00000117394SLC2A1C0006142Malignant neoplasm of breast1CTD_human
ENSG00000117394SLC2A1C0007102Malignant tumor of colon1CTD_human
ENSG00000117394SLC2A1C0007124Noninfiltrating Intraductal Carcinoma1CTD_human
ENSG00000117394SLC2A1C0007134Renal Cell Carcinoma1CTD_human
ENSG00000117394SLC2A1C0007621Neoplastic Cell Transformation1CTD_human
ENSG00000117394SLC2A1C0008073Developmental Disabilities3CTD_human
ENSG00000117394SLC2A1C0009375Colonic Neoplasms1CTD_human
ENSG00000117394SLC2A1C0011860Diabetes Mellitus, Non-Insulin-Dependent1CTD_human
ENSG00000117394SLC2A1C0020796Profound Mental Retardation1CTD_human
ENSG00000117394SLC2A1C0022333Jacksonian Seizure3CTD_human
ENSG00000117394SLC2A1C0023903Liver neoplasms1CTD_human
ENSG00000117394SLC2A1C0025363Mental Retardation, Psychosocial1CTD_human
ENSG00000117394SLC2A1C0025521Inborn Errors of Metabolism1CTD_human
ENSG00000117394SLC2A1C0025958Microcephaly2CTD_human
ENSG00000117394SLC2A1C0027765nervous system disorder1CTD_human
ENSG00000117394SLC2A1C0029408Degenerative polyarthritis1CTD_human
ENSG00000117394SLC2A1C0031149Peritoneal Neoplasms1CTD_human
ENSG00000117394SLC2A1C0036572Seizures3CTD_human
ENSG00000117394SLC2A1C0085996Child Development Deviations3CTD_human
ENSG00000117394SLC2A1C0085997Child Development Disorders, Specific3CTD_human
ENSG00000117394SLC2A1C0086743Osteoarthrosis Deformans1CTD_human
ENSG00000117394SLC2A1C0149958Complex partial seizures3CTD_human
ENSG00000117394SLC2A1C0234533Generalized seizures3CTD_human
ENSG00000117394SLC2A1C0234535Clonic Seizures3CTD_human
ENSG00000117394SLC2A1C0240991Ataxia, Sensory1CTD_human
ENSG00000117394SLC2A1C0270824Visual seizure3CTD_human
ENSG00000117394SLC2A1C0270844Tonic Seizures3CTD_human
ENSG00000117394SLC2A1C0270846Epileptic drop attack3CTD_human
ENSG00000117394SLC2A1C0278161Ataxia, Motor1CTD_human
ENSG00000117394SLC2A1C0279702Conventional (Clear Cell) Renal Cell Carcinoma1CTD_human
ENSG00000117394SLC2A1C0345904Malignant neoplasm of liver1CTD_human
ENSG00000117394SLC2A1C0345967Malignant mesothelioma1CTD_human
ENSG00000117394SLC2A1C0346990Carcinomatosis of peritoneal cavity1CTD_human
ENSG00000117394SLC2A1C0422850Seizures, Somatosensory3CTD_human
ENSG00000117394SLC2A1C0422852Seizures, Auditory3CTD_human
ENSG00000117394SLC2A1C0422853Olfactory seizure3CTD_human
ENSG00000117394SLC2A1C0422854Gustatory seizure3CTD_human
ENSG00000117394SLC2A1C0422855Vertiginous seizure3CTD_human
ENSG00000117394SLC2A1C0427190Ataxia, Truncal1CTD_human
ENSG00000117394SLC2A1C0494475Tonic - clonic seizures3CTD_human
ENSG00000117394SLC2A1C0520966Abnormal coordination1CTD_human
ENSG00000117394SLC2A1C0678222Breast Carcinoma1CTD_human
ENSG00000117394SLC2A1C0750937Ataxia, Appendicular1CTD_human
ENSG00000117394SLC2A1C0750940Tremor, Rubral1CTD_human
ENSG00000117394SLC2A1C0751056Non-epileptic convulsion3CTD_human
ENSG00000117394SLC2A1C0751110Single Seizure3CTD_human
ENSG00000117394SLC2A1C0751123Atonic Absence Seizures3CTD_human
ENSG00000117394SLC2A1C0751494Convulsive Seizures3CTD_human
ENSG00000117394SLC2A1C0751495Seizures, Focal3CTD_human
ENSG00000117394SLC2A1C0751496Seizures, Sensory3CTD_human
ENSG00000117394SLC2A1C0917816Mental deficiency1CTD_human
ENSG00000117394SLC2A1C0919267ovarian neoplasm1CTD_human
ENSG00000117394SLC2A1C1140680Malignant neoplasm of ovary1CTD_human
ENSG00000117394SLC2A1C1176475Ductal Carcinoma1CTD_human
ENSG00000117394SLC2A1C1257931Mammary Neoplasms, Human1CTD_human
ENSG00000117394SLC2A1C1266042Chromophobe Renal Cell Carcinoma1CTD_human
ENSG00000117394SLC2A1C1266043Sarcomatoid Renal Cell Carcinoma1CTD_human
ENSG00000117394SLC2A1C1266044Collecting Duct Carcinoma of the Kidney1CTD_human
ENSG00000117394SLC2A1C1306837Papillary Renal Cell Carcinoma1CTD_human
ENSG00000117394SLC2A1C1332347Atypical Ductal Breast Hyperplasia1CTD_human
ENSG00000117394SLC2A1C1458155Mammary Neoplasms1CTD_human
ENSG00000117394SLC2A1C1832855CHOREOATHETOSIS/SPASTICITY, EPISODIC1CTD_human
ENSG00000117394SLC2A1C1837206Cryohydrocytosis, Stomatin-Deficient, with Mental Retardation, Seizures, Cataracts, and Massive Hepatosplenomegaly1CTD_human
ENSG00000117394SLC2A1C1842534DYSTONIA 18 (disorder)1CTD_human
ENSG00000117394SLC2A1C1847501Glut1 Deficiency Syndrome4CTD_human
ENSG00000117394SLC2A1C1956147Microlissencephaly2CTD_human
ENSG00000117394SLC2A1C2239176Liver carcinoma1CTD_human
ENSG00000117394SLC2A1C3495874Nonepileptic Seizures3CTD_human
ENSG00000117394SLC2A1C3714756Intellectual Disability1CTD_human
ENSG00000117394SLC2A1C3853041Severe Congenital Microcephaly2CTD_human
ENSG00000117394SLC2A1C4048158Convulsions3CTD_human
ENSG00000117394SLC2A1C4316903Absence Seizures3CTD_human
ENSG00000117394SLC2A1C4317109Epileptic Seizures3CTD_human
ENSG00000117394SLC2A1C4317123Myoclonic Seizures3CTD_human
ENSG00000117394SLC2A1C4505436Generalized Absence Seizures3CTD_human
ENSG00000117394SLC2A1C4704874Mammary Carcinoma, Human1CTD_human